KLEMPNERIN BIOLOGISEN SODANKÄYNNIN LABORATORIO

[Bb]

Lähettäjä: Soijuv Lähetetty: 5.2.2007 15:10

Kaikki borrelioosiin sairastuneet tuntevat Klempnerin tutkimuksen borrelioosin hoidosta. Hänen tutkimukseensa lääkärit ympäri maailmaa viittaavat, kun haluavat osoittaa ettei pidennetyistä antibioottihoidosita ole mitään hyötyä. Nyt Klempnerin biologiseen sodankäyntiin erikoistunut laboratorio on joutunut tutkinnan alle. Amerikassa esitetään välillä näkökantojaa siitä että borreliabakteeria olisi käytetty biologisen sodankäynnin välineenä ja siitä johtuisi tiettyjen tahojen Borrelioosia koskeva vähättely esim. IDSA:n lääkäreiden joihin Klempnerkin kuuluu.


http://www.google.com/search?hl=en&q=kl ... gle+Search

http://www.ace-ej.org/BiolabWeb/Debunking.html

--
http://www.actionlyme.org



(Klempner) Biowarfare Lab Being Sued

Date: Saturday, February 03, 2007 5:09:50 PM

http://southendnews.com/ME2/Audiences/dirmod.asp?
Issue Date: 2/1/2007, Posted On: 1/31/2007
BioLab lawsuit leads to new environmental review
Chris Orchard corchard@southendnews.com

A more in-depth environmental review of the BioLab, currently beingconducted by the National Institutes of Health (NIH) and Boston UniversityMedical Center (BUMC) as part of federal court proceedings, will consider the hypothetical risks of placing the BioLab in either Tyngsborough or Peterborough, N.H., according to court filings.

This environmental review will also examine several hypotheticalworst-case scenarios that weren't addressed in previous reviews of theBioLab project. New worst-case scenarios considered will include thehypothetical infection of a laboratory worker with Ebola; the transportationof tick-born encephalitis; an aerosol event involving a hemorrhagic fever;and the use of recombinant DNA (rDNA) research of monkey pox.

The BioLab, as it's commonly known, refers to the National EmergingInfectious Diseases Laboratories (NEIDL) currently under construction onAlbany Street in the South End. Specifically, the NEIDL would contain a highlevel Biosafety Level 4 (BSL4) laboratory that would study dangerouspathogens and diseases such as Ebola and anthrax. The Albany Street buildingwould also house lower security BSL2 and BSL3 laboratories.

BUMC received a $128 million grant from the NIH in 2003 to construct andoperate the BioLab, and received final NIH approval to move ahead with the project in February 2006. However, in May 2006, 10 South End and Roxbury residents sued the NIH, arguing it failed to fully comply with the NationalEnvironmental Policy Act (NEPA) process. An argument at the center of thelawsuit is that the NEPA review failed to fully consider worst-casescenarios.

The original Final Environmental Impact Statement (FEIS) studied the hypothetical aerosol release of anthrax. Plaintiffs in the lawsuit alsoargued that the NEPA review didn't consider alternative, less populated,sites for constructing the BioLab.

At a court hearing in December, lawyers for the NIH and BUMC agreed toconduct a further environmental review of the BioLab that would considermore worst-case scenarios and alternative sites.

According to court filings, this review is expected to be complete byApril. It will be treated as a supplement to the FEIS, per NEPA regulations,initiating a process that will include public meetings and the acceptance ofpublic comments.

In addition, BUMC and the NIH are working with plaintiffs in the lawsuitto ensure public participation in the upcoming process. Plaintiffs havefiled with the court suggested guidelines outlining methods for notifyingthe public of meetings and rules for conducting hearings, among otherthings.